Ultrasound-Guided Intermediate Cervical Plexus Block for Transcarotid Transcatheter Aortic Valve Replacement

J Cardiothorac Vasc Anesth. 2021 Jun;35(6):1747-1750. doi: 10.1053/j.jvca.2020.08.053. Epub 2020 Aug 28.

Abstract

Objective: To report the authors' initial experience of transcarotid transcatheter aortic valve replacement (TAVR) managed with ultrasound-guided intermediate cervical plexus block.

Design: A single-center prospective study.

Setting: A teaching hospital in Paris, France.

Participants: All consecutive patients undergoing a transcarotid TAVR were included.

Interventions: The ultrasound-guided intermediate cervical plexus block was performed in 28 of 31 patients. In 3 patients, the procedure was scheduled under general anesthesia: 2 because of failure of previous transfemoral procedures under local anesthesia, and 1 for an emergency procedure in a pulmonary edema context.

Measurements and main results: Anesthesia and all perioperative parameters were recorded, as well as any complications after the procedure. Twenty-eight patients were managed with intermediate cervical plexus block and light sedation without any anesthesia-related complication. No conversion to general anesthesia was required. The use of vasopressor was only required in 11% of the patients. In 2 patients, a loss of consciousness after the common carotid artery cross-clamping test occurred, leading to the use of a temporary femoral-carotid shunt; no other change in consciousness was recorded during the procedure.

Conclusions: Ultrasound-guided intermediate cervical plexus block appeared to be an alternative anesthetic technique for carotid TAVR, providing adequate surgical conditions, continuous neurologic monitoring, and arterial pressure stability.

Keywords: TAVR; anesthesia; aortic stenosis; high-risk patients; intermediate cervical plexus block.

MeSH terms

  • Aortic Valve / surgery
  • Aortic Valve Stenosis* / diagnostic imaging
  • Aortic Valve Stenosis* / surgery
  • Cervical Plexus Block* / adverse effects
  • France
  • Humans
  • Prospective Studies
  • Transcatheter Aortic Valve Replacement* / adverse effects
  • Treatment Outcome
  • Ultrasonography, Interventional